Medical Care
Global Anti-inflammatory Therapeutics Market Research Report 2025
- Apr 16, 25
- ID: 201719
- Pages: 87
- Figures: 84
- Views: 3
The global market for Anti-inflammatory Therapeutics was valued at US$ 124330 million in the year 2024 and is projected to reach a revised size of US$ 187100 million by 2031, growing at a CAGR of 6.1% during the forecast period.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics.
The Anti-inflammatory Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapeutics.
The Anti-inflammatory Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-inflammatory Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Segment by Type
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-inflammatory Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapeutics Market Perspective (2020-2031)
2.2 Global Anti-inflammatory Therapeutics Growth Trends by Region
2.2.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-inflammatory Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Anti-inflammatory Therapeutics Market Dynamics
2.3.1 Anti-inflammatory Therapeutics Industry Trends
2.3.2 Anti-inflammatory Therapeutics Market Drivers
2.3.3 Anti-inflammatory Therapeutics Market Challenges
2.3.4 Anti-inflammatory Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-inflammatory Therapeutics Revenue
3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2024
3.5 Global Key Players of Anti-inflammatory Therapeutics Head office and Area Served
3.6 Global Key Players of Anti-inflammatory Therapeutics, Product and Application
3.7 Global Key Players of Anti-inflammatory Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapeutics Breakdown Data by Type
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2026-2031)
5 Anti-inflammatory Therapeutics Breakdown Data by Application
5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size (2020-2031)
6.2 North America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
6.4 North America Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapeutics Market Size (2020-2031)
7.2 Europe Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
7.4 Europe Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-inflammatory Therapeutics Market Size (2020-2031)
9.2 Latin America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Details
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Details
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapeutics Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapeutics Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Details
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapeutics Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.12.5 TEVA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Anti-inflammatory Biologics
1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.2.4 Corticosteroids
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anti-inflammatory Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Arthritis
1.3.3 Respiratory Diseases
1.3.4 Dermatology
1.3.5 Gastroenterology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-inflammatory Therapeutics Market Perspective (2020-2031)
2.2 Global Anti-inflammatory Therapeutics Growth Trends by Region
2.2.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-inflammatory Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Anti-inflammatory Therapeutics Market Dynamics
2.3.1 Anti-inflammatory Therapeutics Industry Trends
2.3.2 Anti-inflammatory Therapeutics Market Drivers
2.3.3 Anti-inflammatory Therapeutics Market Challenges
2.3.4 Anti-inflammatory Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapeutics Players by Revenue
3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-inflammatory Therapeutics Revenue
3.4 Global Anti-inflammatory Therapeutics Market Concentration Ratio
3.4.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2024
3.5 Global Key Players of Anti-inflammatory Therapeutics Head office and Area Served
3.6 Global Key Players of Anti-inflammatory Therapeutics, Product and Application
3.7 Global Key Players of Anti-inflammatory Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-inflammatory Therapeutics Breakdown Data by Type
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2026-2031)
5 Anti-inflammatory Therapeutics Breakdown Data by Application
5.1 Global Anti-inflammatory Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size (2020-2031)
6.2 North America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
6.4 North America Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-inflammatory Therapeutics Market Size (2020-2031)
7.2 Europe Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
7.4 Europe Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Anti-inflammatory Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-inflammatory Therapeutics Market Size (2020-2031)
9.2 Latin America Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Anti-inflammatory Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
11.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.3.5 Amgen Inc Recent Development
11.4 AstraZeneca PLC
11.4.1 AstraZeneca PLC Company Details
11.4.2 AstraZeneca PLC Business Overview
11.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.4.5 AstraZeneca PLC Recent Development
11.5 Pfizer, Inc
11.5.1 Pfizer, Inc Company Details
11.5.2 Pfizer, Inc Business Overview
11.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.5.5 Pfizer, Inc Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Anti-inflammatory Therapeutics Introduction
11.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Anti-inflammatory Therapeutics Introduction
11.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.7.5 Roche Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Anti-inflammatory Therapeutics Introduction
11.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.8.5 Merck Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
11.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Details
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.10.5 GlaxoSmithKline Recent Development
11.11 Sun Pharmaceutical Industries Ltd
11.11.1 Sun Pharmaceutical Industries Ltd Company Details
11.11.2 Sun Pharmaceutical Industries Ltd Business Overview
11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.11.5 Sun Pharmaceutical Industries Ltd Recent Development
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Anti-inflammatory Therapeutics Introduction
11.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2020-2025)
11.12.5 TEVA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Anti-inflammatory Biologics
Table 3. Key Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Others
Table 6. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Anti-inflammatory Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Anti-inflammatory Therapeutics Market Share by Region (2020-2025)
Table 10. Global Anti-inflammatory Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Anti-inflammatory Therapeutics Market Share by Region (2026-2031)
Table 12. Anti-inflammatory Therapeutics Market Trends
Table 13. Anti-inflammatory Therapeutics Market Drivers
Table 14. Anti-inflammatory Therapeutics Market Challenges
Table 15. Anti-inflammatory Therapeutics Market Restraints
Table 16. Global Anti-inflammatory Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Anti-inflammatory Therapeutics Market Share by Players (2020-2025)
Table 18. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2024)
Table 19. Ranking of Global Top Anti-inflammatory Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Anti-inflammatory Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Anti-inflammatory Therapeutics, Product and Application
Table 23. Global Key Players of Anti-inflammatory Therapeutics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-inflammatory Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Table 27. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2026-2031)
Table 29. Global Anti-inflammatory Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Table 31. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2026-2031)
Table 33. North America Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Anti-inflammatory Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Anti-inflammatory Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Anti-inflammatory Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Anti-inflammatory Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Anti-inflammatory Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Anti-inflammatory Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-inflammatory Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 48. AbbVie Company Details
Table 49. AbbVie Business Overview
Table 50. AbbVie Anti-inflammatory Therapeutics Product
Table 51. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Johnson & Johnson Company Details
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Anti-inflammatory Therapeutics Product
Table 56. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. Amgen Inc Company Details
Table 59. Amgen Inc Business Overview
Table 60. Amgen Inc Anti-inflammatory Therapeutics Product
Table 61. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 62. Amgen Inc Recent Development
Table 63. AstraZeneca PLC Company Details
Table 64. AstraZeneca PLC Business Overview
Table 65. AstraZeneca PLC Anti-inflammatory Therapeutics Product
Table 66. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 67. AstraZeneca PLC Recent Development
Table 68. Pfizer, Inc Company Details
Table 69. Pfizer, Inc Business Overview
Table 70. Pfizer, Inc Anti-inflammatory Therapeutics Product
Table 71. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 72. Pfizer, Inc Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Anti-inflammatory Therapeutics Product
Table 76. Novartis Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Anti-inflammatory Therapeutics Product
Table 81. Roche Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Anti-inflammatory Therapeutics Product
Table 86. Merck Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Anti-inflammatory Therapeutics Product
Table 91. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. GlaxoSmithKline Company Details
Table 94. GlaxoSmithKline Business Overview
Table 95. GlaxoSmithKline Anti-inflammatory Therapeutics Product
Table 96. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 97. GlaxoSmithKline Recent Development
Table 98. Sun Pharmaceutical Industries Ltd Company Details
Table 99. Sun Pharmaceutical Industries Ltd Business Overview
Table 100. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
Table 101. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 102. Sun Pharmaceutical Industries Ltd Recent Development
Table 103. TEVA Company Details
Table 104. TEVA Business Overview
Table 105. TEVA Anti-inflammatory Therapeutics Product
Table 106. TEVA Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 107. TEVA Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Anti-inflammatory Therapeutics Picture
Figure 2. Global Anti-inflammatory Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-inflammatory Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Anti-inflammatory Biologics Features
Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features
Figure 6. Corticosteroids Features
Figure 7. Others Features
Figure 8. Global Anti-inflammatory Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Anti-inflammatory Therapeutics Market Share by Application: 2024 VS 2031
Figure 10. Arthritis Case Studies
Figure 11. Respiratory Diseases Case Studies
Figure 12. Dermatology Case Studies
Figure 13. Gastroenterology Case Studies
Figure 14. Others Case Studies
Figure 15. Anti-inflammatory Therapeutics Report Years Considered
Figure 16. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Anti-inflammatory Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Anti-inflammatory Therapeutics Market Share by Region: 2024 VS 2031
Figure 19. Global Anti-inflammatory Therapeutics Market Share by Players in 2024
Figure 20. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2024
Figure 22. North America Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
Figure 24. United States Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
Figure 28. Germany Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Region (2020-2031)
Figure 36. China Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
Figure 44. Mexico Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
Figure 48. Turkey Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 53. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 54. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 55. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 57. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 59. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 61. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 62. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Anti-inflammatory Biologics
Table 3. Key Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 4. Key Players of Corticosteroids
Table 5. Key Players of Others
Table 6. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Anti-inflammatory Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Anti-inflammatory Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Anti-inflammatory Therapeutics Market Share by Region (2020-2025)
Table 10. Global Anti-inflammatory Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Anti-inflammatory Therapeutics Market Share by Region (2026-2031)
Table 12. Anti-inflammatory Therapeutics Market Trends
Table 13. Anti-inflammatory Therapeutics Market Drivers
Table 14. Anti-inflammatory Therapeutics Market Challenges
Table 15. Anti-inflammatory Therapeutics Market Restraints
Table 16. Global Anti-inflammatory Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Anti-inflammatory Therapeutics Market Share by Players (2020-2025)
Table 18. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2024)
Table 19. Ranking of Global Top Anti-inflammatory Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Anti-inflammatory Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Anti-inflammatory Therapeutics, Product and Application
Table 23. Global Key Players of Anti-inflammatory Therapeutics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anti-inflammatory Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2020-2025)
Table 27. Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2026-2031)
Table 29. Global Anti-inflammatory Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2020-2025)
Table 31. Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Anti-inflammatory Therapeutics Revenue Market Share by Application (2026-2031)
Table 33. North America Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Anti-inflammatory Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Anti-inflammatory Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Anti-inflammatory Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Anti-inflammatory Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Anti-inflammatory Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Anti-inflammatory Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Anti-inflammatory Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Anti-inflammatory Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 48. AbbVie Company Details
Table 49. AbbVie Business Overview
Table 50. AbbVie Anti-inflammatory Therapeutics Product
Table 51. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Johnson & Johnson Company Details
Table 54. Johnson & Johnson Business Overview
Table 55. Johnson & Johnson Anti-inflammatory Therapeutics Product
Table 56. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 57. Johnson & Johnson Recent Development
Table 58. Amgen Inc Company Details
Table 59. Amgen Inc Business Overview
Table 60. Amgen Inc Anti-inflammatory Therapeutics Product
Table 61. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 62. Amgen Inc Recent Development
Table 63. AstraZeneca PLC Company Details
Table 64. AstraZeneca PLC Business Overview
Table 65. AstraZeneca PLC Anti-inflammatory Therapeutics Product
Table 66. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 67. AstraZeneca PLC Recent Development
Table 68. Pfizer, Inc Company Details
Table 69. Pfizer, Inc Business Overview
Table 70. Pfizer, Inc Anti-inflammatory Therapeutics Product
Table 71. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 72. Pfizer, Inc Recent Development
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Anti-inflammatory Therapeutics Product
Table 76. Novartis Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 77. Novartis Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Anti-inflammatory Therapeutics Product
Table 81. Roche Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Anti-inflammatory Therapeutics Product
Table 86. Merck Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 87. Merck Recent Development
Table 88. Sanofi Company Details
Table 89. Sanofi Business Overview
Table 90. Sanofi Anti-inflammatory Therapeutics Product
Table 91. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 92. Sanofi Recent Development
Table 93. GlaxoSmithKline Company Details
Table 94. GlaxoSmithKline Business Overview
Table 95. GlaxoSmithKline Anti-inflammatory Therapeutics Product
Table 96. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 97. GlaxoSmithKline Recent Development
Table 98. Sun Pharmaceutical Industries Ltd Company Details
Table 99. Sun Pharmaceutical Industries Ltd Business Overview
Table 100. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product
Table 101. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 102. Sun Pharmaceutical Industries Ltd Recent Development
Table 103. TEVA Company Details
Table 104. TEVA Business Overview
Table 105. TEVA Anti-inflammatory Therapeutics Product
Table 106. TEVA Revenue in Anti-inflammatory Therapeutics Business (2020-2025) & (US$ Million)
Table 107. TEVA Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Anti-inflammatory Therapeutics Picture
Figure 2. Global Anti-inflammatory Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti-inflammatory Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Anti-inflammatory Biologics Features
Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features
Figure 6. Corticosteroids Features
Figure 7. Others Features
Figure 8. Global Anti-inflammatory Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Anti-inflammatory Therapeutics Market Share by Application: 2024 VS 2031
Figure 10. Arthritis Case Studies
Figure 11. Respiratory Diseases Case Studies
Figure 12. Dermatology Case Studies
Figure 13. Gastroenterology Case Studies
Figure 14. Others Case Studies
Figure 15. Anti-inflammatory Therapeutics Report Years Considered
Figure 16. Global Anti-inflammatory Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Anti-inflammatory Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Anti-inflammatory Therapeutics Market Share by Region: 2024 VS 2031
Figure 19. Global Anti-inflammatory Therapeutics Market Share by Players in 2024
Figure 20. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapeutics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2024
Figure 22. North America Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
Figure 24. United States Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
Figure 28. Germany Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Anti-inflammatory Therapeutics Market Share by Region (2020-2031)
Figure 36. China Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
Figure 44. Mexico Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Anti-inflammatory Therapeutics Market Share by Country (2020-2031)
Figure 48. Turkey Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Anti-inflammatory Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 52. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 53. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 54. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 55. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 57. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 59. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 61. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 62. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Coke Oven Inspection Intelligent Robot Market Research Report 2025
Apr 16, 25
Global Explosion-Proof Fire Extinguishing Reconnaissance Robot Market Research Report 2025
Apr 16, 25
Global Electric Wheeled Inspection Robot Market Research Report 2025
Apr 16, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232